- Open Access
Transcriptional analysis of the innate immune response of ducks to different species-of-origin low pathogenic H7 avian influenza viruses
Virology Journal volume 10, Article number: 94 (2013)
Wild waterfowl, including ducks, represent the classic reservoir for low pathogenicity avian influenza (LPAI) viruses and play a major role in the worldwide dissemination of AIV. AIVs belonging to the hemagglutinin (H) 7 subtype are of epidemiological and economic importance due to their potential to mutate into a highly pathogenic form of the virus. Thus far, however, relatively little work has been conducted on elucidating the host-pathogen interactions of ducks and H7 LPAIVs. In the current study, three H7 LPAIVs isolated from either chicken, duck, or turkey avian species were evaluated for their comparative effect on the transcriptional innate immune response of ducks.
Three H7 LPAIV isolates, chicken-origin (A/chicken/Maryland/MinhMa/2004), duck-origin (A/pintail/Minnesota/423/1999), and turkey-origin (A/turkey/Virginia/SEP-67/2002) were used to infect Pekin ducks. At 3 days post-infection, RNA from spleen tissue was used for transcriptional analysis using the Avian Innate Immune Microarray (AIIM) and quantitative real-time RT-PCR (qRT-PCR). Microarray analysis revealed that a core set of 61 genes was differentially regulated in response to all three LPAIVs. Furthermore, we observed 101, 135, and 628 differentially expressed genes unique to infection with the chicken-, duck-, or turkey-origin LPAIV isolates, respectively. qRT-PCR results revealed significant (p<0.05) induction of IL-1β, IL-2, and IFNγ transcription, with the greatest induction observed upon infection with the chicken-origin isolate. Several key innate immune pathways were activated in response to LPAIV infection including the toll-like receptor and RIG-I-like receptor pathways.
Pekin ducks elicit a unique innate immune response to different species-of-origin H7 LPAIV isolates. However, twelve identifiable genes and their associated cell signaling pathways (RIG-I, NOD, TLR) are differentially expressed regardless of isolate origin. This core set of genes are critical to the duck immune response to AI. These data provide insight into the potential mechanisms employed by ducks to tolerate AI viral infection.
The study of host pathogen interactions between ducks and avian influenza virus (AIV) is vital to an understanding of the global transmission of avian influenza (AI). The two pathotypes of AI – low pathogenicity (LP) and high pathogenicity (HP) are classified based on their pathogenicity in chickens and the amino acid sequence at the hemagglutinin cleavage site . Of particular interest are the H5 and H7 subtypes of AIV, the two hemagglutinin subtypes that have historically mutated from the LP to HP forms .
The experiments described herein were part of a larger study published by Spackman et al. in which the pathogenesis of 12 North American H7 LPAIV isolates were evaluated in three avian species: specific pathogen free (SPF) white leghorn chickens (Gallus gallus domesticus), broad breasted white turkeys (Meleagris galopova) and Pekin ducks (Anas platyrhynchos domesticus). The Spackman et al. study concluded that the severity of disease and the degree of virus shed relied on specific combinations of species and isolates. Additionally, they concluded that turkeys may be more susceptible to clinical disease from the H7 LPAI than either chickens or ducks.
This report expands the previous study to examine the transcriptional response of ducks to LPAIV. Our 4,959 element avian innate immunity microarray (AIIM) has been successfully used to evaluate the transcriptomic response of several avian species to various microbial challenges, including ducks and avian influenza . In the present study, we utilized the AIIM to characterize the global host immune response of ducks to three H7 low pathogenicity avian influenza (LPAIV) isolates. The aim of this study was to evaluate the consequences of H7 LPAIV infection in ducks with viruses isolated from chickens, ducks, and turkeys.
To elucidate the host mechanisms employed in response to LPAIV infection, we evaluated gene expression changes of the natural host (ducks) to different isolates of LPAIV. We hypothesized that the species-of-origin of an isolate would induce different gene expression patterns related to the innate immune response in Pekin ducks. Gene expression in response to LPAIV infection has been studied in duck: peripheral blood mononuclear cells (PBMC) , lung cell cultures , intestine , and lung, spleen, and lymphatic tissues . In support of the growing research interest in the duck transcriptional immune response, Crowley et al. performed a proof-of-concept microarray study of Pekin ducks infected with high pathogenicity avian influenza virus (HPAIV) H5N1 (A/MuscovyDuck/Vietnam/453/2004).
Adams et al. studied the effects of an H11N9 LPAIV on duck PBMC . In their studies, they noted consistent up-regulation of interleukin 6 (IL6), interferon-alpha (IFNA), interferon gamma (IFNG), and interleukin 2 (IL2) at 8, 24, and 36 hours post-infection (hpi), minimal gene expression changes in toll-like receptor 7 and MHC I and II gene expression (<3.0 fold), and down-regulation of interleukin 1-beta (IL1B). The authors concluded that the cytokine responses demonstrate a skew towards a weak Th1 response in duck PBMC and the absence of signs of disease in ducks correlated with low pro-inflammatory cytokine levels. Additionally, Adams et al. concluded that, in comparison to the chicken response to LPAIV, the lower overall expression of IFNs by duck PBMC in response to AIV infection results in a longer viral shedding duration (persistence) and weaker viral clearance.
Fleming-Capua et al. 2011  studied the duck splenic immune response to LPAIV (A/mallard/BC/500/05 (H5N2)) and observed no gene expression changes in cytokines important in the signaling and extravasation of dendritic cells and naïve lymphocytes to secondary lymphoid tissues (CCL19 and CCL21). This finding led the authors to conclude that ducks experience a weakened adaptive immune response to LPAIV versus HPAIV.
Our study compares immune related gene expression of ducks infected with different species-of-origin LPAIV isolates.
Pathogenesis of LPAIV in Pekin ducks
Clinical disease signs, depression, anorexia, neurological signs, and death, were not observed in Pekin ducks infected with any of the three LPAIV isolates from days 2 through 14 days post-infection (d.p.i.). Three days after infection with LPAIV, three birds from each treatment group were sampled for detection of gross and microscopic lesions. Microscopic lesions were observed in ducks infected with the chicken-origin virus (CK/MD/MinhMa), specifically in the respiratory tract with one bird having rare heterophils in the nasal cavity and rare mucoheterophilic infiltrate in the lumen of a secondary bronchus. Another bird had luminal detritis and multifocal mucosa-associated lymphoid tissue (MALT) hyperplasia in the nasal cavity and patchy cilial loss while the third bird had focal and minimal seroheterophilichistiocytic serositis of the kidney . Microscopic lesions were also noted in ducks infected with the duck-origin (PT/MN/423/99) LPAIV. Specifically, Pekin ducks displayed heterophils in the sloughing or desquamating surface epithelium of the nasal cavity in two of three birds with one of these birds having a focal peracute hemorrhage in the endocardium of the heart while the third bird had no significant lesions. Finally, microscopic lesions were also noted in ducks infected with turkey-origin (TK/VA/67) virus. One duck exhibited pulmonary lesions of bacteria containing heterophilic granulomatous exudate, another bird showed surface bacterial growth on edematous eroding mucosal epithelium in the nasal cavity, and the third bird showed no significant lesions . While lesions were noted in most of the H7 LPAIV-infected ducks, there were no statistically significant differences in gross lesions among the LPAIV isolates.
Absolute quantification qRT-PCR was performed by Spackman et al. in order to quantify the amount of virus genomic material (AIV matrix gene) present in the OP and CL swabs and determine viral shed and relative viral titers. The duration of viral shedding was used to determine viral persistence, that is, how long each virus isolate was maintained within the sampled areas (oral-pharyngeal or cloacal). The three LPAIV isolates in this experiment demonstrated different virus recovery and persistence characteristics. As shown in Figure 1, the duck-origin LPAIV (PT/MN/423/99) virus had the highest recovery in the OP swabs throughout the experiment, while the chicken-origin (CK/MD/MinhMa) and turkey-origin (TK/VA/67) viruses did not display significantly different virus shedding (except on day 10). Significant differences (p<0.05) among the virus isolates were observed in persistence and recovery when examining CL swabs, as shown in Figure 1. There was both greater recovery and longer persistence of the duck-origin LPAIV virus (PT/MN/423/99) with virus being recovered throughout the 14 day time course, when compared to the chicken- and turkey- origin viruses, in which virus recovery was only demonstrated on days 2 and 7 post-infection.
Modulation of gene expression in ducks by LPAIVs
At 3 d.p.i. spleens were harvested and RNA was extracted for use in a microarray experiment utilizing the AIIM. To characterize the transcriptional immune response to LPAIV, we analyzed all of the two-fold differentially regulated genes in each of the three LPAIV infections to find genes unique to a specific species-of-origin isolate or common to all isolates. Combining all three LPAIV-infected treatment groups, there was more down-regulation (1198) than up-regulation (559) of duck splenic genes. There were 101, 135 and 628 2-fold differentially expressed genes unique to infection with the chicken-, duck-, and turkey-origin LPAIV isolates respectively (Figure 2). The number of elements that were up- or down-regulated in response to infection with the chicken-origin virus (CK/MD/MinhMa) was approximately evenly distributed between up- and down-regulated genes (108 and 133, respectively). Additionally, infection with CK/MD/MinhMa yielded the smallest number of differentially expressed genes (241/1757, or 14% of the differentially expressed genes). The number of elements that were down-regulated (352) in response to infection with the duck-origin virus (PT/MN/423) was greater than the number of up-regulated elements (142). The proportion of differentially expressed genes responding to the duck-origin virus (PT/MN/423) was 28% (494/1,757). Finally, the greatest number of differentially expressed genes (1,022) were observed in response to infection with the turkey-origin virus (TK/VA/67), comprising 58% of all differentially expressed genes. Furthermore, 70% (712/1,022) of these differentially expressed genes were down-regulated, and only 30% were up-regulated (310).
Gene list and gene ontology analysis
Gene Ontology (GO) analysis was conducted in order to examine overall trends in the microarray data, and the subset of differentially expressed genes common to all three LPAIV infections. To identify the biological pathways activated in response to LPAIV infection, we submitted a total of 1,757 Entrez Gene IDs (1,198 2-fold down- and 559 2-fold up-regulated) to GORetriever to obtain GO IDs. GORetriever output was then analyzed in DAVID’s functional annotation tools. Out of the 1,757 genes, 621 genes had DAVID IDs and 10 statistically significant (p<0.05) canonical signaling pathways found in the Kyoto Encyclopedia of Genes and Genomes (KEGG). Functional analyses of the GO terms associated with these gene lists revealed differences in KEGG pathways that were either stimulated or repressed in response to LPAIV infection (Table 1).
To analyze the commonality of the innate immune response amongst all three LPAIV infections, we compared differentially expressed (2 fold up- or down-regulated) genes from each infection and identified the union of these gene lists. Sixty-one genes were differentially expressed in response to all three LPAIV infections (Figure 2), indicating that ducks differentially regulated the same 61 genes regardless of the H7 LPAIV avian-origin isolate. Due to the current completeness of annotation of the chicken genome and the mammalian-bias in functional annotation software, of the 61 differentially expressed genes, our bioinformatics analysis identified 13 genes for functional annotation.
Functional analyses of the GO terms analyzed in DAVID are summarized in Table 2. AIIM data confirms a consistent, amongst all three species-of-origin LPAIV isolate infections, down-regulation of JUN (jun oncogene) and PMM2 (phosphomannomutase 2). JUN is a key regulator of several innate immune pathways and PMM2 functions in several metabolic pathways. The 13 genes were categorized according to their representation in one or more canonical KEGG pathways. Of the 13 genes, 69% (9/13) belong to innate immune pathways illustrating an unsurprising enrichment of genes involved in the immune response to avian influenza. Evidence exists for an association between influenza infection and the subsequent differential regulation of several genes in our list, such as cadherin 1 , ATPase , mago-nashi homolog , proteasome 26S subunit , and ribosomal protein L35a .
Gene expression modulation by LPAIVs (qRT-PCR)
Since the AIIM is a chicken-transcriptome-based microarray used in a cross-species hybridization experiment and a more qualitative than quantitative tool, qRT-PCR using primers derived from duck-specific gene sequences was performed. Select publicly available duck immune gene sequences were analyzed using qRT-PCR to obtain quantitative levels of gene expression of interferon-α (IFNA), interferon-β (IFNB), interferon-γ (IFNG), interleukin-1β (IL1B), interleukin-2 (IL2), interleukin-6 (IL6), major histocompatibility complex class I (MHCI), major histocompatibility complex class II (MHCII), and toll-like receptor 7 (TLR7). These genes were selected for their known role in the response to AIV and their function in innate immunity.
Figure 3 illustrates the changes in gene expression of the interleukins, MHCs, and TLR7. IL2 demonstrated the greatest level of gene expression induction in response to all three LPAIV infections, especially during infection with CK/MD/MinhMa (19.7 fold up-regulation). IL2 was up-regulated by 7.8 and 9.1 fold for the PT/MN/423 and TK/VA/67 infections respectively. IL1B gene expression was up-regulated in response to infection with all three LPAIV isolates as well, with the greatest gene expression changes in the CK/MD/MinhMa infection at 8.2 fold. Minimal gene expression changes (<2.5 fold up-regulated) were observed for IL6, MHCI, MHCII, and TLR7.
Gene expression changes in the interferon genes are illustrated in Figure 4. The results for IFNA were not statistically significant at p<0.05, however, the results for IFNB and IFNG were statistically significant and demonstrated a 4.3 fold increase in IFNB expression in ducks infected with the turkey-origin LPAIV isolate (TK/VA/67). Large up-regulation of IFNG was seen in ducks infected with the chicken-origin isolate (8.9 fold) and in ducks infected with the turkey-origin isolate (7.1 fold).
In the current study, we aimed to characterize the pathogenomic host response of ducks to different species-of-origin low pathogenicity avian influenza isolates. Spackman et al. evaluated the comparative pathogenesis of twelve isolates of H7 LPAIV on chickens, ducks, and turkeys. Specifically, they assessed pathogenesis by measuring clinical signs, viral replication titers, immunohistochemistry, and seroconversion. These methods provided insight into the pathogenesis of H7 LPAIV isolates, revealing that turkeys may be more susceptible to clinical disease than chickens or ducks, and that disease severity and the degree of virus shed was dependent on specific species and isolate combinations. To build upon the Spackman et al. study and investigate the molecular mechanisms of innate immunity in Pekin ducks, we utilized microarrays and qRT-PCR in order to qualify and quantify gene expression changes in response to LPAIV. Three H7 LPAI viruses were evaluated for their effect on the transcriptional activity of the duck spleen at 3 d.p.i..The three H7 LPAI viruses described in Table 1 of the Spackman et al. study  have been characterized by their isolate identification, subtype, source, hemagglutinin cleavage site, neuraminidase stalk deletion, and nonstructural gene subtype and consisted of chicken-origin A/chicken/MD/MinhMa/2004 (H7N2), duck-origin A/pintail/MN/423/1999 (H7N3), and turkey-origin A/turkey/VA/SEP-67/2002 (H7N2) LPAI viruses. For our experiment, we selected Pekin ducks that were infected with H7 LPAI viruses isolated from chickens, ducks, or turkeys, representing three different species-of-origin influenza isolates.
Based on the pathobiology of LPAI viruses, and as previously reported, ducks exhibited no clinical signs in response to LPAIV infection [3, 16]. With respect to the pathology of the H7 LPAIV isolates used in this study, the highest AIV qRT-PCR titers were observed in both the OP and CL swabs of ducks in response to the duck-origin virus (PT/MN/423). OP titers were highest at 2 d.p.i. (104.9 Log10 titer), while cloacal titers peaked at 4 d.p.i. (105.2 Log10 titer). Both OP and CL titers remained positive through 14 d.p.i.. This finding demonstrates the adaptation of PT/MN/423 to the duck host. Given the absence of clinical signs and the limited observance of gross and microscopic lesions, the replication of AIV is indicative of active AI infection and demonstrates that ducks are managing viral pathogenesis in ways other than decreasing viral replication, suggesting they use alternate strategies to prevent disease signs.
In order to evaluate gene expression changes caused by the different species-of-origin LPAIV isolates, we utilized our avian innate immune microarray (AIIM) to characterize the transcriptomic response of ducks to LPAIV. By hybridizing RNA from infected duck spleens to our 4,959 element microarray, we were able to survey the transcriptional profiles of a critical immune organ during LPAIV infection. In general, more genes were down-regulated (1197) than up-regulated (558) (Figure 2). One hypothesis for this finding is that perhaps ducks, as asymptomatic carriers and the natural reservoir for AIV, tolerate infection due in part to down-regulation of their immune system. The overall down-regulation of immunity-related genes observed in our microarray data adds to a possible mechanistic explanation of how ducks tolerate AIV infection. In fact, disease tolerance is now being considered a distinct host defense strategy, employed by a wide variety of species . Ducks may be able to fine-tune their innate immune response, differentially regulating the TLR, NOD-like receptor (NLR), cytokine-cytokine receptor interaction, and TGF-beta signaling pathways (Table 1), bypassing the negative consequences associated with AIV infection. Regardless of the origin of the LPAIV isolate, infected ducks induce both the TLR and NLR pathways, while they repress cytokine-cytokine receptor interaction pathways. Immune regulation represents one probable mechanism ducks consistently use to tolerate LPAIV infections.
AIIM data revealed two genes, JUN and PMM2, of the core set of 61 differentially expressed genes that were consistently down-regulated and found to be the most highly repressed genes (data not shown). JUN is a cellular component of the activating protein 1 (AP-1) transcription factor complex and is also a key regulator of the mitogen activated protein kinase (MAPK), influenza A, and Toll-like receptor signaling pathways . JUN has also been shown to play a role in both the negative and positive regulation of viral transcription, according to the curated gene expression studies in the NextBio database (Santa Clara, CA). Recently, JUN has been demonstrated to be differentially regulated, and specifically down-regulated during LPAIV infection, in a gene expression study of avian influenza infected lung cell lines . A plausible role for the down-regulation of JUN could be the host’s manipulation of its own transcriptional machinery in order to prevent tissue damage or unchecked influenza virus replication. Another gene exhibiting consistent down-regulation is phosphomannomutase 2 (PMM2), a gene found in metabolic pathways such as amino sugar and nucleotide sugar metabolism (gga00520) and fructose and mannose metabolism (gga00051) . Interestingly, differential regulation of PMM2 has been associated with virus infection of chicken embryo fibroblast cell cultures, thus providing an additional line of evidence supporting PMM2 down-regulation in our study .
The cellular pathways activated in response to LPAIV infection in ducks confirmed an innate immune response at the transcriptional level (Table 2). Activation of the nucleotide oligomerization domain (NOD), TLR, and retinoic acid inducible gene-I (RIG-I) pathways is noteworthy, as these are primary signaling pathways in the innate immune response to AIV. Specifically, NLR signaling regulates inflammation and apoptotic cascades, while TLR signaling activates the NFKB, MAPK, and type I interferon pathways . RIG-I has recently gained attention due to the fact that it is absent in chickens and present in ducks, providing a potential explanation for the differential immune responses and susceptibility between these two birds . These pathways intersect at critical signaling molecules and also trigger other immune pathways (apoptosis, lymphocyte recruitment, proteolysis, MAPK signaling) and the production of interferons, cytokines, and chemokines , pathways and proteins critical in combating influenza infection.
An emphasis on the innate immune response of the ducks to AIV is warranted given that the strength of the innate response largely determines the strength of the subsequent adaptive immune response . Additionally, it has been demonstrated that ducks lack a substantial humoral immune response to AIV [24–26], inferring an increased reliance on innate immune mechanisms. Furthermore, a robust innate immune response has been correlated to increased mean death time and decreased morbidity in Pekin ducks in response to HPAIV challenge .
Our qRT-PCR findings provide insight into possible host defense mechanisms in LPAIV-infected ducks. There were some overall similarities between this study and the results described by Adams et al. with respect to disease pathogenesis and the cytokine responses of ducks to LPAIV despite the fact that our studies used different tissues (PBMC versus spleen), time points (8, 12, 36 hpi versus 72 hpi), and LPAIV subtypes (H11N9 versus H7N2 or H7N3). Specifically, the lack of clinical signs and low-level expression of IL6 is supported by the Adams et al. study and human studies in which a positive correlation between the severity of clinical signs and IL6 plasma levels was demonstrated . It was interesting to note the up-regulation of the pro-inflammatory cytokine, interleukin 2 (IL2) (Figure 3). IL2 has been implicated in the protective role of the mouse host against lethal influenza virus challenge  and is highly expressed in duck embryonic fibroblasts in response to HP H5N1 avian influenza infection . Inferences regarding a type II interferon response can also be made since the type II interferon (IFNG) was up-regulated in response to the chicken- and turkey-origin LPAIV isolates (8.9 and 7.1 fold, respectively) (Figure 4). IFNG up-regulation has been demonstrated in duck PBMC in response to a duck-origin H11N9 LPAIV infection . Taken together, these results point to a type II-mediated IFN response that ducks utilize to combat LPAIV infections caused by isolates that are not duck-origin. Modulation of these critical innate immune genes provides further evidence of duck immune system fine-tuning of the innate immune response to different isolates of H7 LPAIV.
In conclusion, we have identified several immune pathways that are activated in response to LPAIV infection of ducks. While many of these pathways have been previously associated with influenza virus infection, this study identified new cellular pathways associated LPAIV infected ducks, such as the fructose and mannose metabolism (gga00051) and amino sugar and nucleotide sugar metabolism (gga00520) pathways. Additionally, we have gained further insight into the differences and similarities among innate immune responses based on the avian species from which the LPAIV was isolated. A core set of 61 genes was differentially expressed during all three LPAIV infections while 101, 135, and 628 genes were uniquely differentially expressed in response to the chicken-, duck-, and turkey-origin isolates respectively, indicating the importance of host-adaptation of LPAIV on transcriptional immune responses. Further studies will be required to elucidate the virus and host mechanisms controlling gene expression during infection and to understand what factors contribute to the differential host immune response.
Three H7 LPAI viruses were selected to represent different species of origin (Table 3). Viruses were propagated and titrated in 9 to 11 day-old embryonated chicken eggs by standard procedures . The chicken-origin isolate (A/chicken/Maryland/MinhMa/2004) was described in 2004 by Ladman et al. during an outbreak in 6-wk-old commercial broilers on the Minh Ma Farm in Wicomico County, Maryland. The duck-origin isolate (A/pintail/Minnesota/423/1999) was described in 2005 by Spackman et al. during an evaluation of North American AIV natural reservoirs (free-flying waterfowl). The turkey-origin isolate (A/turkey/Virginia/SEP-67/2002) was described in 2002 by Spackman et al. during a commercial turkey farm outbreak in Virginia, West Virginia, and North Carolina.
Pekin ducks (Anas platyrhynchos domesticus) were obtained from commercial hatcheries at day of age and were housed in negative pressure glove-port isolators (Allentown Caging, Allentown, NJ) under biosafety level 3 containment conditions in the Charles C. Allen Biotechnology Laboratory at the University of Delaware. Ducks were obtained from flocks with no antibody or prior exposure to AI virus. The ducks were provided with ad libitum access to feed and water before and after exposure to the viruses. Ducks were cared for in accordance with established humane procedures and University of Delaware biosecurity guidelines.
Evaluation of viral pathogenicity in pekin ducks
Fifteen Pekin ducks were separated into four treatment groups: Group 1 – Non-infected controls, Group 2 - CK/MD/MinhMa inoculated, Group 3 - PT/MN/423 inoculated, and Group 4 - TK/VA/67 inoculated. At 2 weeks of age, each duck was inoculated with 106 EID50 per bird in 0.1 ml by the intrachoanal (cleft palate) route. Birds were monitored daily for clinical disease signs which were scored as follows: 0 = no clinical signs, 1 = mild depression, 2 = moderate to severe (i.e. depressed, not eating, neurological signs), 3 = dead. Oral-pharyngeal (OP) and cloacal (CL) swabs were collected at 2, 4, 7, 10 and 14 days post-inoculation (d.p.i.) to evaluate virus shed by quantitative real-time RT-PCR (qRT-PCR) . Three d.p.i., 3 birds from each treatment group were euthanized and necropsied to evaluate gross lesions and collect spleens. One hundred mg of spleen tissue was collected from each bird, and stored in 5–10 volumes of RNAlater at −80°C for RNA isolation and subsequent microarray and qRT-PCR analysis.
Spleen samples from each of the three birds selected for necropsy were pooled according to treatment group. Total cellular RNA was isolated from 100 mg of spleen tissue using the RNeasy Midi RNA Purification Kit (Qiagen Inc., Valencia, CA) according to the manufacturer’s protocols. The optional DNaseI on-column digestion step was employed to remove any trace or contaminating duck genomic DNA from the samples. RNA quantity was determined using a Nanodrop 1000 (Nanodrop, Wilmington, DE), and RNA quality was assessed using the Agilent RNA 6000 Nano Assay Protocol in the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). RNA Integrity Numbers (RINs) were obtained for each sample to confirm sample quality.
RNA amplification, fluorescent labeling, and hybridization
One μg of total cellular RNA from each treatment group pool was amplified into amino allyl modified RNA (aRNA) using the Ambion Amino Allyl MessageAmp II aRNA Amplification Kit (Ambion Inc., Austin, TX) using two rounds of amplification and following the manufacturer’s instructions. Ten ug of aRNA mixed with 9 μL of coupling buffer was fluorescently labeled with Alexa Fluor 555 (Invitrogen, Carlsbad, CA) and resuspended in 11 μL of DMSO. The labeling reaction was performed at room temperature for 3 hours in the dark. Post-labeling aRNA purification, post-hybridization washes, and microarray slide scanning were performed as previously described  and hybridization to the AIIM was conducted at 42°C overnight.
Microarray data analysis
Spot and background intensities were acquired using GenePix Pro 4.1 Software (Molecular Devices, Sunnyvale, CA). Abnormal spots (dust, bubbles in the hybridization solution) were removed from further analysis. Spot intensity was determined using a local background subtraction method. Data from analyzed slides was imported to GeneSpring v7.3 (Agilent Technologies, Santa Clara, CA). Each experimental slide was compared to the control slide (non-infected duck spleen) to determine relative spot intensities, and differential gene expression. A gene list was created from those elements that appeared in two of the three replicate spot locations in each slide, in all three experimental conditions (i.e. infections with either the chicken-, duck-, or turkey- species-of-origin LPAI isolates). Subsets of this gene list consisting of two-fold differentially regulated genes from each infected treatment group were exported for further pathway and gene ontology (GO) analysis. Lists of differentially expressed genes were created using GeneSpring v7.3. The corresponding Entrez Gene IDs were imported to AgBase v2.0 GORetriever to obtain GO IDs . The GORetriever GO ID output was then analyzed in The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 [36, 37]. Functional annotation and gene functional annotation analyses were performed using DAVID, which provided batch annotation and GO term enrichment analysis to highlight the most relevant GO terms associated with the input gene list. Further DAVID analysis yielded the significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways represented in the data set.
Quantitative real-time RT-PCR (qRT-PCR)
qRT-PCR targeting select duck immune genes was performed on the splenic RNA samples (Table 4). Primer sequences were kindly provided by Dr. Darrell Kapczynski (DK, personal communication) and Dr. Carol Cardona as referenced. qRT-PCR was performed with aliquots of RNA from the same samples that were used in the AIIM microarray analysis. Gene expression levels of mRNA transcripts were determined by qRT-PCR using a QuantiTect SYBR Green RT-PCR kit (Qiagen). qRT-PCR was performed for each sample in triplicate on an ABI 7900HT Sequence Detection System (Life Technologies Corp., Carlsbad, CA). The amplification procedure was performed in a 20 μL reaction volume containing 300 nM of each primer and 100 ng of RNA. The following thermal-cycling conditions were used: reverse transcription (30 min at 50°C), PCR initial activation (15 min at 95°C), and 40 cycles of denaturation (15 sec at 94°C), annealing (30 sec at 55°C), and extension (30 sec at 72°C). Data were analyzed using SDS2.3 (Life Technologies Corp.).
qRT-PCR data and statistical analysis
Average cycle threshold (Ct) values for each target gene were normalized by the Ct value of an endogenous control gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Relative gene expression data were analyzed using the Livak and Schmittgen 2-ΔΔCt method  and ΔCt values were calculated by subtracting average GAPDH Ct values from average target gene Ct values. Normalized Ct values (ΔCt) from LPAIV infected samples was compared to the ΔCt from non-infected control duck spleen samples, the difference (ΔΔCt) being transformed into 2-ΔΔCt value as the estimated fold change of the experimental sample (infected) over the control (non-infected) sample. The three replicate Ct values for each gene were analyzed by one-way ANOVA (p<0.05) to determine the statistical significance between means of individual genes. A post-hoc statistical test, Tukey-Kramer minimum significant differences (MSD), was utilized to analyze the differences amongst means of genes grouped by LPAIV isolate (p<0.05).
Low pathogenicity avian influenza
Avian influenza virus
Avian innate immunity microarray
Low pathogenicity avian influenza
Peripheral blood mononuclear cells
quantitative real-time RT-PCR
Kyoto Encyclopedia of Genes and Genomes
Database for Annotation, Visualization and Integrated Discovery
Major histocompatibility complex class I
Major histocompatibility complex class II
Toll-like receptor 7
Activating protein 1
Mitogen activated protein kinase
Nucleotide oligomerization domain
Retinoic acid inducible gene-I
Amino allyl modified RNA
Minimum significant differences
Lee C, Lee Y, Swayne D, Senne D, Linares D, Suarez D: Assessing potential pathogenicity of avian influenza virus: current and experimental system. Avian Dis 2007, 51: 260-263. 10.1637/7572-033106R.1
Alexander D: A review of avian influenza in different bird species. Vet Microbiol 2000, 74: 3-13. 10.1016/S0378-1135(00)00160-7
Spackman E, Gelb J, Preskenis LA, Ladman BS, Pope CR, Pantin-Jackwood MJ, McKinley ET: The pathogenesis of low pathogenicity H7 avian influenza viruses in chickens, ducks and turkeys. Virology J 2010, 7: 331. 10.1186/1743-422X-7-331
Keeler C, Bliss T, Lavric M, Maughan M: A functional genomics approach to the study of avian innate immunity. Cytogenet Genome Res 2007, 117: 139-145. 10.1159/000103174
Adams SC, Xing Z, Li JL, Cardona CJ: Immune-related gene expression in response to H11N9 low pathogenic avian influenza virus infection in chicken and Pekin duck peripheral blood mononuclear cells. Molec Immunol 2009, 46: 1744-1749. 10.1016/j.molimm.2009.01.025
Jiang H, Yang H, Kapczynski DR: Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species. Virology J 2011, 8: 447. 10.1186/1743-422X-8-447
Volmer C, Soubies SM, Grenier B, Guerin JL, Volmer R: Immune response in the duck intestine following infection with low-pathogenic avian influenza viruses or stimulation with a Toll-like receptor 7 agonist administered orally. J Gen Virol 2011, 92: 534-543. 10.1099/vir.0.026443-0
Fleming-Canepa X, Brusnyk C, Aldridge JR, Ross KL, Moon D, Wang D, Xia J, Barber MRW, Webster RG, Magor KE: Expression of duck CCL19 and CCL21 and CCR7 receptor in lymphoid and influenza-infected tissues. Molec Immunol 2011, 48: 1950-1957. 10.1016/j.molimm.2011.05.025
Crowley TM, Haring VR, Burggraaf S, Moore RJ: Application of chicken microarrays for gene expression analysis in other avian species. BMC Genomics 2009, 10: S3.
Preskenis L: Characterization of recent North American low-pathogenicity avian influenza H7 isolates in SPF leghorns, turkeys, and Pekin ducks. Animal and Food Sciences Department: M.S. thesis. University of Delaware; 2010.
Lu Y, Qian XY, Krug RM: The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 1994, 8: 1817-1828. 10.1101/gad.8.15.1817
Guinea R, Carrasco L: Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol 1995, 69: 2306-2312.
Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, Wittkowski KM, Piqueras B, Banchereau J, Palucka AK, Chaussabel D: Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007, 109: 2066-2077. 10.1182/blood-2006-02-002477
Shapira SD, Gat-Viks I, Shum BOV, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N: A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139: 1255-1267. 10.1016/j.cell.2009.12.018
Parnell G, McLean A, Booth D, Huang S, Nalos M, Tang B: A Aberrant cell cycle and apoptotic changes characterise severe influenza A infection - a meta-analysis of genomic signatures in circulating leukocytes. PLoS One 2011, 6: e17186. 10.1371/journal.pone.0017186
Swayne DE, Halvorson DA: Influenza. In Diseases of Poultry. 12th edition. Edited by: Saif YM, Fadly A, Glisson J, McDougald L, Nolan L, Swayne DE. Ames, IA: Blackwell; 2008:1324.
Medzhitov R, Schneider DS, Soares MP: Disease tolerance as a defense strategy. Science 2012, 335: 936-941. 10.1126/science.1214935
Kanehisa M, Goto S: KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28: 27-30. 10.1093/nar/28.1.27
Chakrabarti AK, Vipat VC, Mukherjee S, Singh R, Pawar SD, Mishra AC: Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses. Virology J 2010, 7: 219. 10.1186/1743-422X-7-219
Maslikowski BM, Neel BD, Wu Y, Wang LZ, Rodrigues NA, Gillet G, Bedard PA: Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer. BMC Cancer 2010, 10: 41. 10.1186/1471-2407-10-41
Kaiser P: Advances in avian immunology-prospects for disease control: a review. Avian Pathol 2010, 39: 309-324. 10.1080/03079457.2010.508777
Barber MRW, Aldridge JR, Webster RG, Magor KE: Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci USA 2010, 107: 5913-5918. 10.1073/pnas.1001755107
Lee M, Kim Y: Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 2007, 76: 447-480. 10.1146/annurev.biochem.76.060605.122847
Magor KE: Immunoglobulin genetics and antibody responses to influenza in ducks. Dev Comp Immunol 2011, 35: 1008-1017. 10.1016/j.dci.2011.02.011
Kida H, Yanagawa R, Matsuoka Y: Duck influenza lacking evidence of disease signs and immune response. Infect Immun 1980, 30: 547-553.
Philpott MS, Easterday BC, Hinshaw VS: Antigenic and phenotypic variants of a virulent avian influenza virus selected during replication in ducks. J Wildl Dis 1989, 25: 507-513.
Cagle C, Thanh Long T, Tung N, Wasilenko J, Adams SC, Cardona CJ, Spackman E, Suarez DL, Pantin-Jackwood MJ: Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine. Vaccine 2011, 29: 6549-6557. 10.1016/j.vaccine.2011.07.004
Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG: Symptom pathogenesis during acute influenza: Interleukin-6 and other cytokine responses. J Med Virol 2001, 64: 262-268. 10.1002/jmv.1045
Henke A, Rohland N, Zell R, Wutzler P: Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections. Intervirology 2006, 49: 249-252. 10.1159/000092487
Liang Q-l, Luo J, Zhou K, Dong J-x, He H-x: Immune-related gene expression in response to H5N1 avian influenza virus infection in chicken and duck embryonic fibroblasts. Molec Immunol 2011, 48: 924-930. 10.1016/j.molimm.2010.12.011
Woolcock PR: Avian influenza virus isolation and propagation in chicken eggs. In Methods Mol Biol. Volume 436. Edited by: Spackman E. Totowa, NJ: Humana Press; 2008:35-46.
Ladman BS, Rosenberger SC, Rosenberger JK, Pope CR, Gelb J: Virulence of low pathogenicity H7N2 avian influenza viruses from the Delmarva Peninsula for broiler and leghorn chickens and turkeys. Avian Dis 2008, 52: 623-631. 10.1637/8282-031208-Reg.1
Spackman E, Stallknecht DE, Slemons RD, Winker K, Suarez DL, Scott M, Swayne DE: Phylogenetic analyses of type A influenza genes in natural reservoir species in North America reveals genetic variation. Virus Res 2005, 114: 89-100. 10.1016/j.virusres.2005.05.013
Spackman E, Senne DA, Davison S, Suarez DL: Sequence analysis of recent H7 avian influenza viruses associated with three different outbreaks in commercial poultry in the United States. J Virol 2003, 77: 13399-13402. 10.1128/JVI.77.24.13399-13402.2003
McCarthy FM, Wang N, Magee GB, Nanduri B, Lawrence ML, Camon EB, Barrell DG, Hill DP, Dolan ME, Williams WP: AgBase: a functional genomics resource for agriculture. BMC Genomics 2006, 7: 229. 10.1186/1471-2164-7-229
Huang DW, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37: 1-13. 10.1093/nar/gkn923
Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4: 44-57.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(−Delta Delta C) method. Methods 2001, 25: 402-408. 10.1006/meth.2001.1262
The authors gratefully acknowledge Dr. John McDonald for his statistical guidance on this work. This work was supported by USDA-ARS CRIS Project #6612-32000-048 and USDA-ARS cooperative agreement #58-6612-6-245.
The authors declare that they have no competing interests.
ES was involved in virus selection and experimental design. JG was involved in virus selection and experimental design. BL and LP conducted animal experiments, collected specimens, ran qRT-PCR, and serological assays. CK, LD, and MM designed the microarray and qRT-PCR experiments targeting immune genes. LD and MM performed the microarray experiments. MM performed the qRT-PCR data and statistical analysis. All authors contributed to manuscript preparation. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Maughan, M.N., Dougherty, L.S., Preskenis, L.A. et al. Transcriptional analysis of the innate immune response of ducks to different species-of-origin low pathogenic H7 avian influenza viruses. Virol J 10, 94 (2013). https://doi.org/10.1186/1743-422X-10-94
- Innate immunity
- Avian influenza
- Low pathogenicity
- Avian innate immunity microarray (AIIM)